Bottacini F, van Sinderen D and Ventura M: Omics of bifidobacteria: Research and insights into their health-promoting activities. Biochem J. 474:4137–4152. 2017. View Article : Google Scholar : PubMed/NCBI

Biarc J, Nguyen IS, Pini A, Gossé F, Richert S, Thiersé D, Van Dorsselaer A, Leize-Wagner E, Raul F, Klein JP and Schöller-Guinard M: Carcinogenic properties of proteins with pro-inflammatory activity from Streptococcus infantarius (formerly S. bovis). Carcinogenesis. 25:1477–1484. 2004. View Article : Google Scholar : PubMed/NCBI

Wei C, Xun AY, Wei XX, Yao J, Wang JY, Shi RY, Yang GH, Li YX, Xu ZL, Lai MG, et al: Bifidobacteria expressing tumstatin protein for antitumor therapy in tumor-bearing mice. Technol Cancer Res Treat. 15:498–508. 2016. View Article : Google Scholar : PubMed/NCBI

Liboredo JC, Anastácio LR, Pelúzio Mdo C, Valente FX, Penido LC, Nicoli JR and Correia MI: Effect of probiotics on the development of dimethylhydrazine-induced preneoplastic lesions in the mice colon. Acta Cir Bras. 28:367–372. 2013. View Article : Google Scholar : PubMed/NCBI

Lai LR, Hsieh SC, Huang HY and Chou CC: Effect of lactic fermentation on the total phenolic, saponin and phytic acid contents as well as anti-colon cancer cell proliferation activity of soymilk. J Biosci Bioeng. 115:552–556. 2013. View Article : Google Scholar : PubMed/NCBI

Kim KA, Jung IH, Park SH, Ahn YT, Huh CS and Kim DH: Comparative analysis of the gut microbiota in people with different levels of ginsenoside Rb1 degradation to compound K. PloS One. 8:e624092013. View Article : Google Scholar : PubMed/NCBI

Schroeder BO, Birchenough GMH, Stahlman M, Arike L, Johansson MEV, Hansson GC and Bäckhed F: Bifidobacteria or fiber protects against diet-induced microbiota-mediated colonic mucus deterioration. Cell Host Microbe. 23:27–40.e7. 2018. View Article : Google Scholar : PubMed/NCBI

Thum C, Roy NC, McNabb WC, Otter DE and Cookson AL: In vitro fermentation of caprine milk oligosaccharides by bifidobacteria isolated from breast-fed infants. Gut Microbes. 6:352–363. 2015. View Article : Google Scholar : PubMed/NCBI

Asakuma S, Hatakeyama E, Urashima T, Yoshida E, Katayama T, Yamamoto K, Kumagai H, Ashida H, Hirose J and Kitaoka M: Physiology of consumption of human milk oligosaccharides by infant gut-associated bifidobacteria. J Biol Chem. 286:34583–34592. 2011. View Article : Google Scholar : PubMed/NCBI

Ku S, You HJ, Park MS and Ji GE: Effects of ascorbic acid on α-l-arabinofuranosidase and α-l-arabinopyranosidase activities from RD47 and its application to whole cell bioconversion of ginsenoside. J Korean Soc Appl Biol Chem. 58:857–865. 2015. View Article : Google Scholar : PubMed/NCBI

Egan M, Motherway MO, Kilcoyne M, Kane M, Joshi L, Ventura M and van Sinderen D: Cross-feeding by Bifidobacterium breve UCC2003 during co-cultivation with Bifidobacterium bifidum PRL2010 in a mucin-based medium. BMC Microbiol. 14:2822014. View Article : Google Scholar : PubMed/NCBI

Bayoumi MA and Griffiths MW: In vitro inhibition of expression of virulence genes responsible for colonization and systemic spread of enteric pathogens using Bifidobacterium bifidum secreted molecules. Int J Food Microbiol. 156:255–263. 2012. View Article : Google Scholar : PubMed/NCBI

Kim JE, Kim JY, Lee KW and Lee HJ: Cancer chemopreventive effects of lactic acid bacteria. J Microbiol Biotechnol. 17:1227–1235. 2007.PubMed/NCBI

Oikarinen S, Heinonen S, Karppinen S, Mättö J, Adlercreutz H, Poutanen K and Mutanen M: Plasma enterolactone or intestinal Bifidobacterium levels do not explain adenoma formation in multiple intestinal neoplasia (Min) mice fed with two different types of rye-bran fractions. Br J Nutr. 90:119–125. 2003. View Article : Google Scholar : PubMed/NCBI

Bindels LB, Neyrinck AM, Salazar N, Taminiau B, Druart C, Muccioli GG, Francois E, Blecker C, Richel A, Daube G, et al: Non digestible oligosaccharides modulate the gut microbiota to control the development of leukemia and associated cachexia in mice. PloS One. 10:e01310092015. View Article : Google Scholar : PubMed/NCBI

Silva Oliveira E, de Carvalho Cruz T, Parshikov IA, dos Santos Alves R, Emery Silva F and Furtado Jacometti Cardoso NA: Cytotoxicity of lapachol metabolites produced by probiotics. Lett Appl Microbiol. 59:108–114. 2014. View Article : Google Scholar : PubMed/NCBI

Hidaka A, Hamaji Y, Sasaki T, Taniguchi S and Fujimori M: Exogenous cytosine deaminase gene expression in Bifidobacterium breve I-53-8w for tumor-targeting enzyme/ prodrug therapy. Biosci Biotechnol Biochem. 71:2921–2926. 2007. View Article : Google Scholar : PubMed/NCBI

Nakamura T, Sasaki T, Fujimori M, Yazawa K, Kano Y, Amano J and Taniguchi S: Cloned cytosine deaminase gene expression of Bifidobacterium longum and application to enzyme/pro-drug therapy of hypoxic solid tumors. Biosci Biotechnol Biochem. 66:2362–2366. 2002. View Article : Google Scholar : PubMed/NCBI

Bae EA, Park SY and Kim DH: Constitutive beta-glucosidases hydrolyzing ginsenoside Rb1 and Rb2 from human intestinal bacteria. Biol Pharm Bull. 23:1481–1485. 2000. View Article : Google Scholar : PubMed/NCBI

Apás AL, Dupraz J, Ross R, González SN and Arena ME: Probiotic administration effect on fecal mutagenicity and microflora in the goat's gut. J Biosci Bioeng. 110:537–540. 2010. View Article : Google Scholar : PubMed/NCBI

Lo PR, Yu RC, Chou CC and Huang EC: Determinations of the antimutagenic activities of several probiotic bifidobacteria under acidic and bile conditions against benzo[a]pyrene by a modified Ames test. Int J Food Microbiol. 93:249–257. 2004. View Article : Google Scholar : PubMed/NCBI

Osswald A, Westermann C, Sun Z and Riedel CU: A phytase-based reporter system for identification of functional secretion signals in bifidobacteria. PloS One. 10:e01288022015. View Article : Google Scholar : PubMed/NCBI

Jiang L, Xiao X, Ren J, Tang Y, Weng H, Yang Q, Wu M and Tang W: Proteomic analysis of bladder cancer indicates Prx-I as a key molecule in BI-TK/GCV treatment system. PloS One. 9:e987642014. View Article : Google Scholar : PubMed/NCBI

Xiao X, Jin R, Li J, Bei Y and Wei T: The antitumor effect of suicide gene therapy using Bifidobacterium infantis-mediated herpes simplex virus thymidine kinase/ganciclovir in a nude mice model of renal cell carcinoma. Urology. 84(982): e15–e20. 2014.PubMed/NCBI

Reddy BS: Possible mechanisms by which pro- and prebiotics influence colon carcinogenesis and tumor growth. J Nutr. 129 7 Suppl:S1478–S1482. 1999. View Article : Google Scholar

Rodrigues MA, Silva LA, Salvadori DM, De Camargo JL and Montenegro MR: Aberrant crypt foci and colon cancer: Comparison between a short- and medium-term bioassay for colon carcinogenesis using dimethylhydrazine in Wistar rats. Braz J Med Biol Res. 35:351–355. 2002. View Article : Google Scholar : PubMed/NCBI

Kulkarni N and Reddy BS: Inhibitory effect of Bifidobacterium longum cultures on the azoxymethane-induced aberrant crypt foci formation and fecal bacterial beta-glucuronidase. Proc Soc Exp Biol Med. 207:278–283. 1994. View Article : Google Scholar : PubMed/NCBI

Femia AP, Luceri C, Dolara P, Giannini A, Biggeri A, Salvadori M, Clune Y, Collins KJ, Paglierani M and Caderni G: Antitumorigenic activity of the prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis on azoxymethane-induced colon carcinogenesis in rats. Carcinogenesis. 23:1953–1960. 2002. View Article : Google Scholar : PubMed/NCBI

Yin Y, Wang RR, Wang Y, Wang JJ and Xu GX: Preparation of selenium-enriched Bifidobacterium longum and its effect on tumor growth and immune function of tumor-bearing mice. Asian Pac J Cancer Prev. 15:3681–3686. 2014. View Article : Google Scholar : PubMed/NCBI

Sekine K, Toida T, Saito M, Kuboyama M, Kawashima T and Hashimoto Y: A new morphologically characterized cell wall preparation (whole peptidoglycan) from Bifidobacterium infantis with a higher efficacy on the regression of an established tumor in mice. Cancer Res. 45:1300–1307. 1985.PubMed/NCBI

Rowland IR, Rumney CJ, Coutts JT and Lievense LC: Effect of Bifidobacterium longum and inulin on gut bacterial metabolism and carcinogen-induced aberrant crypt foci in rats. Carcinogenesis. 19:281–285. 1998. View Article : Google Scholar : PubMed/NCBI

Simone M, Gozzoli C, Quartieri A, Mazzola G, Di Gioia D, Amaretti A, Raimondi S and Rossi M: The probiotic Bifidobacterium breve B632 inhibited the growth of Enterobacteriaceae within colicky infant microbiota cultures. Biomed Res Int. 2014:3010532014. View Article : Google Scholar : PubMed/NCBI

Mogna L, Del Piano M and Mogna G: Capability of the two microorganisms Bifidobacterium breve B632 and Bifidobacterium breve BR03 to colonize the intestinal microbiota of children. J Clin Gastroenterol. 48 Suppl 1:S37–S39. 2014. View Article : Google Scholar : PubMed/NCBI

Fooks LJ and Gibson GR: Probiotics as modulators of the gut flora. Br J Nutr. 88 Suppl 1:S39–S49. 2002. View Article : Google Scholar : PubMed/NCBI

Dhanani AS and Bagchi T: Lactobacillus plantarum CS24.2 prevents E. coli adhesion to HT-29 cells and also down-regulates enteropathogen induced TNF-α and IL-8 expression. Microbiol Immunol. 57:309–315. 2013. View Article : Google Scholar : PubMed/NCBI

Tareb R, Bernardeau M, Gueguen M and Vernoux JP: In vitro characterization of aggregation and adhesion properties of viable and heat-killed forms of two probiotic Lactobacillus strains and interaction with foodborne zoonotic bacteria, especially Campylobacter jejuni. J Med Microbiol. 62:637–649. 2013. View Article : Google Scholar : PubMed/NCBI

Kolenbrander PE, Palmer RJ Jr, Periasamy S and Jakubovics NS: Oral multispecies biofilm development and the key role of cell-cell distance. Nat Rev Microbiol. 8:471–480. 2010. View Article : Google Scholar : PubMed/NCBI

Cadieux PA, Burton J, Devillard E and Reid G: Lactobacillus by-products inhibit the growth and virulence of uropathogenic Escherichia coli. J Physiol Pharmacol. 60 Suppl 6:S13–S18. 2009.

McMillan A, Dell M, Zellar MP, Cribby S, Martz S, Hong E, Fu J, Abbas A, Dang T, Miller W and Reid G: Disruption of urogenital biofilms by lactobacilli. Colloids Surf B Biointerfaces. 86:58–64. 2011. View Article : Google Scholar : PubMed/NCBI

Velraeds MM, van de Belt-Gritter B, van der Mei HC, Reid G and Busscher HJ: Interference in initial adhesion of uropathogenic bacteria and yeasts to silicone rubber by a Lactobacillus acidophilus biosurfactant. J Med Microbiol. 47:1081–1085. 1998. View Article : Google Scholar : PubMed/NCBI

Apás AL, González SN and Arena ME: Potential of goat probiotic to bind mutagens. Anaerobe. 28:8–12. 2014. View Article : Google Scholar : PubMed/NCBI

Asaduzzaman SM and Sonomoto K: Lantibiotics: Diverse activities and unique modes of action. J Biosci Bioeng. 107:475–487. 2009. View Article : Google Scholar : PubMed/NCBI

Xu HY, Tian WH, Wan CX, Jia LJ, Wang LY, Yuan J, Liu CM, Zeng M and Wei H: Antagonistic potential against pathogenic microorganisms and hydrogen peroxide production of indigenous lactobacilli isolated from vagina of Chinese pregnant women. Biomed Environ Sci. 21:365–371. 2008. View Article : Google Scholar : PubMed/NCBI

Martín R and Suárez JE: Biosynthesis and degradation of H2O2 by vaginal lactobacilli. Appl Environ Microbiol. 76:400–405. 2010. View Article : Google Scholar : PubMed/NCBI

Lankaputhra WE and Shah NP: Antimutagenic properties of probiotic bacteria and of organic acids. Mutat Res. 397:169–182. 1998. View Article : Google Scholar : PubMed/NCBI

Sreekumar O and Hosono A: The antimutagenic properties of a polysaccharide produced by Bifidobacterium longum and its cultured milk against some heterocyclic amines. Can J Microbiol. 44:1029–1036. 1998. View Article : Google Scholar : PubMed/NCBI

Reddy BS: Prevention of colon cancer by pre- and probiotics: Evidence from laboratory studies. Br J Nutr. 80:S219–S223. 1998.PubMed/NCBI

Singh J, Rivenson A, Tomita M, Shimamura S, Ishibashi N and Reddy BS: Bifidobacterium longum, a lactic acid-producing intestinal bacterium inhibits colon cancer and modulates the intermediate biomarkers of colon carcinogenesis. Carcinogenesis. 18:833–841. 1997. View Article : Google Scholar : PubMed/NCBI

Verma A and Shukla G: Probiotics Lactobacillus rhamnosus GG, Lactobacillus acidophilus suppresses DMH-induced procarcinogenic fecal enzymes and preneoplastic aberrant crypt foci in early colon carcinogenesis in Sprague Dawley rats. Nutr Cancer. 65:84–91. 2013. View Article : Google Scholar : PubMed/NCBI

Lee do K, Jang S, Baek EH, Kim MJ, Lee KS, Shin HS, Chung MJ, Kim JE, Lee KO and Ha NJ: Lactic acid bacteria affect serum cholesterol levels, harmful fecal enzyme activity, and fecal water content. Lipids Health Dis. 8:212009. View Article : Google Scholar : PubMed/NCBI

Suerbaum S and Michetti P: Helicobacter pylori infection. N Engl J Med. 347:1175–1186. 2002. View Article : Google Scholar : PubMed/NCBI

El-Serag HB and Rudolph KL: Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis. Gastroenterology. 132:2557–2576. 2007. View Article : Google Scholar : PubMed/NCBI

Swidsinski A, Khilkin M, Kerjaschki D, Schreiber S, Ortner M, Weber J and Lochs H: Association between intraepithelial Escherichia coli and colorectal cancer. Gastroenterology. 115:281–286. 1998. View Article : Google Scholar : PubMed/NCBI

Abdulamir AS, Hafidh RR, Mahdi LK, Al-jeboori T and Abubaker F: Investigation into the controversial association of Streptococcus gallolyticus with colorectal cancer and adenoma. BMC Cancer. 9:4032009. View Article : Google Scholar : PubMed/NCBI

Gupta A, Madani R and Mukhtar H: Streptococcus bovis endocarditis, a silent sign for colonic tumour. Colorectal Dis. 12:164–171. 2010. View Article : Google Scholar : PubMed/NCBI

Bernet MF, Brassart D, Neeser JR and Servin AL: Adhesion of human bifidobacterial strains to cultured human intestinal epithelial cells and inhibition of enteropathogen-cell interactions. Appl Environ Microbiol. 59:4121–4128. 1993.PubMed/NCBI

Kavanaugh DW, O'Callaghan J, Buttó LF, Slattery H, Lane J, Clyne M, Kane M, Joshi L and Hickey RM: Exposure of Bifidobacterium longum subsp. infantis to milk oligosaccharides increases adhesion to epithelial cells and induces a substantial transcriptional response. PloS One. 8:e672242013. View Article : Google Scholar : PubMed/NCBI

Wickramasinghe S, Pacheco AR, Lemay DG and Mills DA: Bifidobacteria grown on human milk oligosaccharides downregulate the expression of inflammation-related genes in Caco-2 cells. BMC Microbiol. 15:1722015. View Article : Google Scholar : PubMed/NCBI

Chichlowski M, De Lartigue G, German JB, Raybould HE and Mills DA: Bifidobacteria isolated from infants and cultured on human milk oligosaccharides affect intestinal epithelial function. J Pediatr Gastroenterol Nutr. 55:321–327. 2012. View Article : Google Scholar : PubMed/NCBI

Gu QY, Zhang J and Feng YC: Role of NLRP3 inflammasome in Bifidobacterium longum-regulated visceral hypersensitivity of postinfectious irritable bowel syndrome. Artif Cells Nanomed Biotechnol. 44:1933–1937. 2016. View Article : Google Scholar : PubMed/NCBI

Wu BB, Yang Y, Xu X and Wang WP: Effects of Bifidobacterium supplementation on intestinal microbiota composition and the immune response in healthy infants. World J Pediatr. 12:177–182. 2016. View Article : Google Scholar : PubMed/NCBI

Wu S, Rhee KJ, Albesiano E, Rabizadeh S, Wu X, Yen HR, Huso DL, Brancati FL, Wick E, McAllister F, et al: A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med. 15:1016–1022. 2009. View Article : Google Scholar : PubMed/NCBI

Mortaz E, Adcock IM, Folkerts G, Barnes PJ, Vos Paul A and Garssen J: Probiotics in the management of lung diseases. Mediators Inflamm. 2013:7510682013. View Article : Google Scholar : PubMed/NCBI

Helwig U, Lammers KM, Rizzello F, Brigidi P, Rohleder V, Caramelli E, Gionchetti P, Schrezenmeir J, Foelsch UR, Schreiber S and Campieri M: Lactobacilli, bifidobacteria and E. coli nissle induce pro- and anti-inflammatory cytokines in peripheral blood mononuclear cells. World J Gastroenterol. 12:5978–5986. 2006. View Article : Google Scholar : PubMed/NCBI

Korn T, Bettelli E, Oukka M and Kuchroo VK: IL-17 and Th17 cells. Ann Rev Immunol. 27:485–517. 2009. View Article : Google Scholar

Lin W, Truong N, Grossman WJ, Haribhai D, Williams CB, Wang J, Martin MG and Chatila TA: Allergic dysregulation and hyperimmunoglobulinemia E in Foxp3 mutant mice. J Allergy Clin Immunol. 116:1106–1115. 2005. View Article : Google Scholar : PubMed/NCBI

Feleszko W, Jaworska J, Rha RD, Steinhausen S, Avagyan A, Jaudszus A, Ahrens B, Groneberg DA, Wahn U and Hamelmann E: Probiotic-induced suppression of allergic sensitization and airway inflammation is associated with an increase of T regulatory-dependent mechanisms in a murine model of asthma. Clin Exp Allergy. 37:498–505. 2007. View Article : Google Scholar : PubMed/NCBI

Sivan A, Corrales L, Hubert N, Williams JB, Aquino-Michaels K, Earley ZM, Benyamin FW, Lei YM, Jabri B, Alegre ML, et al: Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science. 350:1084–1089. 2015. View Article : Google Scholar : PubMed/NCBI

Yin Y, Kou L, Wang JJ and Xu GX: Therapeutic efficacy of Bifidobacterium longum-mediated human interleukin-2 with endostatin or TRAIL in transplanted tumors in mice. Exp Ther Med. 3:481–486. 2012. View Article : Google Scholar : PubMed/NCBI

Bordonaro M, Lazarova DL and Sartorelli AC: Butyrate and Wnt signaling: A possible solution to the puzzle of dietary fiber and colon cancer risk? Cell Cycle. 7:1178–1183. 2008. View Article : Google Scholar : PubMed/NCBI

Mäkivuokko H, Tiihonen K, Tynkkynen S, Paulin L and Rautonen N: The effect of age and non-steroidal anti-inflammatory drugs on human intestinal microbiota composition. Br J Nutr. 103:227–234. 2010. View Article : Google Scholar : PubMed/NCBI

Bergmann KR, Liu SX, Tian R, Kushnir A, Turner JR, Li HL, Chou PM, Weber CR and De Plaen IG: Bifidobacteria stabilize claudins at tight junctions and prevent intestinal barrier dysfunction in mouse necrotizing enterocolitis. Am J Pathol. 182:1595–1606. 2013. View Article : Google Scholar : PubMed/NCBI

Ewaschuk JB, Diaz H, Meddings L, Diederichs B, Dmytrash A, Backer J, Looijer-van Langen M and Madsen KL: Secreted bioactive factors from Bifidobacterium infantis enhance epithelial cell barrier function. Am J Physiol Gastrointest Liver Physiol. 295:G1025–G1034. 2008. View Article : Google Scholar : PubMed/NCBI

Becker S, Oelschlaeger TA, Wullaert A, Vlantis K, Pasparakis M, Wehkamp J, Stange EF and Gersemann M: Bacteria regulate intestinal epithelial cell differentiation factors both in vitro and in vivo. PloS One. 8:e556202013. View Article : Google Scholar : PubMed/NCBI

de Vrese M and Schrezenmeir J: Probiotics, prebiotics, and synbiotics. Adv Biochem Eng Biotechnol. 111:1–66. 2008.PubMed/NCBI

Ricciuti B, Foglietta J, Bianconi V, Sahebkar A and Pirro M: Enzymes involved in tumor-driven angiogenesis: A valuable target for anticancer therapy. Semin Cancer Biol: S1044-579X(17)30043-3. 2017. View Article : Google Scholar

Zhu H, Li Z, Mao S, Ma B, Zhou S, Deng L, Liu T, Cui D, Zhao Y, He J, et al: Antitumor effect of sFlt-1 gene therapy system mediated by Bifidobacterium infantis on Lewis lung cancer in mice. Cancer Gene Ther. 18:884–896. 2011. View Article : Google Scholar : PubMed/NCBI

Sudhakar A and Boosani CS: Inhibition of tumor angiogenesis by tumstatin: Insights into signaling mechanisms and implications in cancer regression. Pharm Res. 25:2731–2739. 2008. View Article : Google Scholar : PubMed/NCBI

Wei C, Xun AY, Wei XX, Yao J, Wang JY, Shi RY, Yang GH, Li YX, Xu ZL, Lai MG, et al: Bifidobacteria expressing tumstatin protein for antitumor therapy in tumor-bearing mice. Technol Cancer Res Treat. 15:498–508. 2016. View Article : Google Scholar : PubMed/NCBI

Yi C, Huang Y, Guo ZY and Wang SR: Antitumor effect of cytosine deaminase/5-fluorocytosine suicide gene therapy system mediated by Bifidobacterium infantis on melanoma. Acta Pharmacol Sin. 26:629–634. 2005. View Article : Google Scholar : PubMed/NCBI

Sasaki T, Fujimori M, Hamaji Y, Hama Y, Ito K, Amano J and Taniguchi S: Genetically engineered Bifidobacterium longum for tumor-targeting enzyme-prodrug therapy of autochthonous mammary tumors in rats. Cancer Sci. 97:649–657. 2006. View Article : Google Scholar : PubMed/NCBI